Topik: JW Therapeutics news
Breakthrough Therapy Designation for Carteyva® in China: Second-line Treatment Focus
Breakthrough Therapy Designation for Carteyva® in China: Second-line Treatment FocusShanghai - JW Therapeutics, a leading biotechnology company, has made a groundbreaking announcement that is set to change the landscape of cancer treatment in China....












